Pricing Log in Create free account

Lunai Bioworks Inc. (LNAI) vs Valion Bio, Inc. (VBIO)

Lunai Bioworks Inc. and Valion Bio, Inc. are both Biotechnology companies. Valion Bio, Inc. is the larger, with a market value of $1.1M against $830.0K — 1.3× the size. Valion Bio, Inc. has the higher net margin (0.00% vs −3,761.9%) and the lower return on invested capital (−61.0% vs 0.00%). Across the 15 metrics below, Lunai Bioworks Inc. leads on 10 and Valion Bio, Inc. on 5.

Valuation

Metric LNAI VBIO Biotechnology median
P/E n/m n/m 10.60
P/S 5.68 0.14 9.40
P/B n/m 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.25 11.09 9.02
Earnings yield (640.81%) (40,026.00%) (32.88%)
Free cash flow yield (988.00%) (22,510.36%) (23.13%)

Profitability

Metric LNAI VBIO Biotechnology median
Gross margin (3.48%) (58.09%) 68.51%
Operating margin (9,184.79%) 0.00% 0.00%
Net margin (3,761.88%) 0.00% 0.00%
Free cash flow margin (5,610.24%) 0.00% 0.00%
Return on equity 23.46% (489.30%) (51.96%)
Return on assets (39.21%) (104.96%) (46.06%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric LNAI VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) 98.77% 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNAI VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 0.11 1.11 4.97
Net debt to EBITDA 0.20 0.79 1.01

Dividend

Metric LNAI VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LNAI VBIO Biotechnology median
Market cap 830.00k 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack